The increasing resistance of human pathogens promotes the development of novel antimicrobial agents. Due to the physical bactericidal mechanism of membrane disruption, antimicrobial peptides are considered as potential therapeutic candidates without inducing microbial resistance. Scorpion venom-derived peptide, Androctonus amoreuxi Antimicrobial Peptide 1 (AamAP1), has been proved to have broad-spectrum antimicrobial properties. However, AamAP1 can induce hemolysis and shows strong toxicity against mammalian cells. Herein, the antimicrobial activity and mechanism of a novel synthetic antimicrobial peptide, GK-19, derived from AamAP1 and its derivatives, was evaluated. Five bacteria and three fungi were used to evaluate the antimicrobial effects of GK-19 in vitro. Scalded mice models combined with skin and soft tissue infections (SSTIs) were used to evaluate its applicability. The results indicated that GK-19 could not only inhibit Gram-positive and Gram-negative bacterial growth, but also kill fungi by disrupting the microbial cell membrane. Meanwhile, GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma. Furthermore, in scalded mice models combined with SSTIs induced by either Methicillin-Resistant Staphylococcus aureus (MRSA) or Candida albicans, GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.
As a common clinical problem, the therapy of SSTIs is facing growing challenges due to an increase in the number of drug-resistant bacteria and fungi. UV C (UVC) light sterilization has been widely used in all aspects of daily life, but there are very few reports about
in vivo
therapy using UVC light.
Background and Purpose: The widespread abuse of antibiotics have led to
increasing resistance of many important human pathogens. The urgent need
to develop novel antimicrobial therapies has stimulated great interest
in antimicrobial peptides as therapeutic candidates for the treatment of
infectious diseases. Scorpion venom-derived peptide Androctonus Amoreuxi
Antimicrobial Peptide 1 (AamAP1) is a new type of host defense peptide
with broad-spectrum but moderate antimicrobial property. Most
importantly, AamAp1 has been proved to be highly hemolytic and displays
significantly high toxicity against mammalian cells. The aim of this
study was to evaluate the antimicrobial activity and mechanism of a
novel synthetic antimicrobial peptide GK-19 deriving from AamAP1 and its
derivatives. Experimental Approach: Five bacteria and three fungi were
used to evaluate the antimicrobial effect of GK-19 in vitro. Mouse
models of scalded combined with skin and soft tissue infections were
used to evaluate the antimicrobial effect of GK-19 in vivo. Key Results:
The results indicated that Gk-19 could not only inhibit Gram-positive
and Gram-negative bacterial growth but also kill fungi by permeabilizing
microbial membrane. Cellular and in vivo studies proved that GK-19
showed negligible toxicity to mammalian cells, low hemolytic activity
and high stability in plasma. Furthermore, in mouse models of scald
combined with skin and soft tissue infections induced by either
Methicillin-Resistant Staphylococcus Aureus (MRSA) or Candida Albicans,
GK-19 showed significant antimicrobial and healing effects. Conclusion
and Implications: The novel scorpion venom-derived peptide analogue
GK-19 is a promising drug candidate in the battle against
multi-resistant bacterial and fungal infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.